ATRX and central nervous system cancer: Moreover, two of the broad CNAs arising with ATRX deficiency in NHAs, involving 12p gain and 14q loss, recapitulated events commonly seen in the IDHmut-noncodel glioma subtype and associated with relatively unfavorable prognosis when present (Fig. 4c–f).